PDF下载 ( 182 KB)
Establishment of multi-disciplinary team for comprehensive treatment of liver cancer-consensus of experts in Guangdong, China (1)
-
摘要:
<正>肝癌是临床上最常见的恶性肿瘤之一,世界范围内,男性的肝癌发病率和病死率分别列恶性肿瘤的第5位和第3位,每年新发肝癌病例和死亡病例中有一半以上发生在中国[1]。据2012中国肿瘤登记年报报道,肝癌已居全国肿瘤登记地区恶性肿瘤发病的第3位(发病率为28.71/10万),死亡原因的第2位(死亡率为26.04/10万)[2]。肝癌的高发性与高致死性对
-
[1] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90. [2] HAO J, CHEN WQ.Chinese Cancer registry annual report (2012) [M].Beijing:Military Medical Science Press, 2012:27-60. (in Chinese) 郝捷, 陈万青.中国肿瘤登记年报 (2012) [M].北京:军事医学科学出版社, 2012:27-60. [3]European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer.EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma[J].J Hepatol, 2012, 56 (4) :908-943. [4]Ministry of Health of the People's Republic of China.Diagnosis, management, and treatment of hepatocellular carcinoma (V2011) [J].Chin Clin Oncol, 2011, 16 (10) :929-946. (in Chinese) 中华人民共和国卫生部.原发性肝癌诊疗规范 (2011年版) [J].临床肿瘤学杂志, 2011, 16 (10) :929-946. [5]GISH RG, LENCIONI R, DI BISCEGLIE AM, et al.Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma[J].Expert Rev Gastroenterol Hepatol, 2012, 6 (2) :173-185. [6]MARRERO JA.Multidisciplinary management of hepatocellular carcinoma:where are we today?[J].Semin Liver Dis, 2013, 33 (Suppl 1) :s3-s10. [7]COHEN GS, BLACK M.Multidisciplinary management of hepatocellular carcinoma:a model for therapy[J].J Multidiscip Healthc, 2013, 6:189-195. [8]CHUN YH, KIM SU, PARK JY, et al.Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma[J].Eur J Cancer, 2011, 47 (17) :2568-2575. [9]MARRERO JA, FONTANA RJ, BARRAT A, et al.Prognosis of hepatocellular carcinoma:comparison of 7 staging systems in an American cohort[J].Hepatology, 2005, 41 (4) :707-716. [10]TANG Z, ZHOU X, LIN Z, et al.Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis[J].Clin Med J (Engl) , 1999, 112 (10) :887-891. [11]CHEN MS, LI JQ, ZHENG Y, et al.A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma[J].Ann Surg, 2006, 243 (3) :321-328. [12]BARONE C, KOEBERLE D, METSELAAR H, et al.Multidisciplinary approach for HCC patients:hepatology for the oncologists[J].Ann Oncol, 2013, 24 (Suppl 2) :ii15-23. [13]SHERMAN M, BURAK K, MAROUN J, et al.Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma[J].Curr Oncol, 2011, 18 (5) :228-240. [14]BURAK KW, KNETEMAN NM.An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC) :the Alberta HCC algorithm[J].Can J Gastroenterol, 2010, 24 (11) :643-650. [15]PARK HC, SEONG J, TANAKA M, et al.Multidisciplinary management of nonresectable hepatocellular carcinoma[J].Oncology, 2011, 81 (Suppl 1) :134-140. [16]CHANG TT, SAWHNEY R, MONTO A, et al.Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival[J].HPB (Oxford) , 2008, 10 (6) :405-411.1112-1115. (in Chinese) -
本文二维码
计量
- 文章访问数: 145
- HTML全文浏览量: 6
- PDF下载量: 320
- 被引次数: 0
下载:
